Ultragenyx Pharmaceutical
RARE
RARE
240 hedge funds and large institutions have $6.24B invested in Ultragenyx Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 78 increasing their positions, 89 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
240
Holders Change
-12
Holders Change %
-4.76%
% of All Funds
4.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
43
Increased
78
Reduced
89
Closed
55
Calls
$6.38M
Puts
$7.52M
Net Calls
-$1.14M
Net Calls Change
-$30.5M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$177M |
| 2 |
2
Alkeon Capital Management
New York
|
$182M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$67.4M |
| 4 |
4
Millennium Management
New York
|
$53.7M |
| 5 |
5
ClearBridge Investments
New York
|
$226M |
